| Date | Title | Description |
| 20.10.2025 | Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances | SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ... |
| 17.10.2025 | Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s | Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price.
Centers for Medi... |
| 17.10.2025 | Cartography Biosciences: $67 Million Series B Closed For Advancing Novel Antibody-Based Oncology Therapies | Cartography Biosciences, a precision oncology company developing next-generation T-cell engaging antibody therapeutics, announced it has closed a $67 million Series B financing to accelerate its differentiated pipeline toward the clinic. Th... |
| 16.10.2025 | Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers | Roche’s Genentech said it will sell its flu pill, Xofluza, directly to certain patients at a discount in a bid to expand access to uninsured people, those with limited coverage or people whose plans don’t cover the drug.
It follows similar ... |
| 16.10.2025 | Trump announces efforts to expand access to IVF drugs | President Donald Trump announced two new efforts to expand availability of in vitro fertilization, the first concrete step from the Trump administration on the expensive, decades-old procedure.
It includes a deal with Germany’s Merck KGaA t... |
| 15.10.2025 | Mission Therapeutics Raises $13.3M in Funding | Mission Therapeutics, a Cambridge, UK-based clinical-stage biotech developing first-in-class therapeutics that promote cell and organ health by enhancing mitophagy, raised $13.3m in funding.
The financing was led by current investors Pfizer... |
| 15.10.2025 | CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation | Wells Fargo CEO Charlie Scharf said AI is boosting productivity but will likely reduce workforce size.
Pfizer CEO Albert Bourla warned China is closing the biotech and pharmaceutical patent gap rapidly and said the U.S. needs to focus on in... |
| 13.10.2025 | Dublin’s Meta-Flux raises €1.8M to decode biology with AI | Meta-Flux, a Dublin-based biotech startup, has raised €1.8M in Seed funding to expand its decision-support platform for preclinical drug development, bridging the gap between preclinical research and clinical application.
Acting as an “AI b... |
| 10.10.2025 | Trump reaches deal with AstraZeneca to lower U.S. drug prices | The Trump administration and AstraZeneca have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S.
President Donald Trump has already agreed to a similar pact with Pfizer, which will sell discounted dr... |
| 06.10.2025 | Pro traders are watching Pfizer after a big move last week and two other stocks with earnings on deck | - |
| 06.10.2025 | European President set to face yet another no-confidence vote | The President of the European Commission, Ursula von der Leyen, is back in Strasbourg to defend herself against a no-confidence motion, just months after her last one.
On Monday evening, two motions of no confidence against the President wi... |
| 03.10.2025 | Drug Price Revolution: Pfizer Deal Ignites Market, Reshapes Industry | A landmark Pfizer deal with the Trump administration significantly alters US drug pricing. The agreement promises lower Medicaid costs and 'most-favored nation' launch pricing for new pharmaceuticals, ensuring Americans pay no more than oth... |
| 02.10.2025 | Exclusive: Trump targets deals in pharma, AI, energy, mining before midterm elections | Exclusive: Trump targets deals in pharma, AI, energy, mining before midterm elections
By Dawn Kopecki, Jarrett Renshaw, Sabrina Valle and Ernest ScheyderOctober 2, 20257:41 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Fa... |
| 02.10.2025 | Сделка Pfizer с США поддержала рост акций фармкомпаний | - |
| 02.10.2025 | FTSE 100 Live: Tesco shares rally; OpenAI nets $500bn price tag | Good morning from the City AM liveblog team.
The FTSE 100 is leading the City higher this morning as it continues to build on records sealed earlier in the week. The index rose 0.2 per cent to 9,464.91 this morning, following on from yester... |
| 01.10.2025 | How Shweta is Turning Compliance into a Competitive Edge in E-Commerce | Share
Share
Share
Share
Email
An expert in regulatory technology and trust programs for global e-commerce marketplaces explains how compliance can shift from a burden to a driver of growth
A recent survey of 50,000 digital shoppers revealed... |
| 01.10.2025 | Wall Street indexes close higher with quarterly and monthly gains even as US government shutdown looms | Wall Street indexes close higher with quarterly and monthly gains even as US government shutdown looms
By Sinéad Carew and Niket NishantSeptember 30, 202510:45 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linked... |
| 01.10.2025 | CNBC Daily Open: A September no investor wanted to sleep on | The U.S. government will shut down. on Oct. 1 midnight stateside.
Berkshire Hathaway reportedly eyeing $10 billion deal.
Pfizer agrees to lower prices for tariff exemption.
U.S. stocks end September higher.
This stock is posed to soar, acco... |
| 01.10.2025 | 5 Things to Know
U.S. government shuts down, Nike earnings, TrumpRX and more in Morning Squawk | The federal government shut down after Congress failed to reach a funding agreement.
Stocks posted a winning month and quarter.
President Donald Trump said Pfizer will sell its medications at lower prices in the U.S.
This is CNBC’s Morning ... |
| 01.10.2025 | Explainer: What does Trump's deal with Pfizer mean for drug prices? | Explainer: What does Trump's deal with Pfizer mean for drug prices?
By Deena BeasleySeptember 30, 202511:50 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
U.S. President Donald Trump announces ... |
| 01.10.2025 | US Pfizer deal powers health stocks as drugmakers court Trump | US Pfizer deal powers health stocks as drugmakers court Trump
By Alun John, Danilo Masoni, Dimitri Rhodes and Maggie FickOctober 1, 20258:01 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Summa... |
| 01.10.2025 | Stocks making the biggest moves midday: Pfizer, Nike, Conagra, Corteva, GEO Group, Tesla, Reddit and more | - |
| 01.10.2025 | Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers | President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer.
Trump’s agreement with Pfizer included a three-yea... |
| 30.09.2025 | Stocks making the biggest moves midday: Pfizer, Semtech, Spotify, UiPath, CoreWeave and more | - |
| 30.09.2025 | 2026 CNBC Changemakers nominations: Why women business leaders on our annual list are more important than ever | CNBC is now accepting nominations for the 2026 Changemakers list. Learn more and submit a nomination by Nov 21.
CNBC is now accepting nominations for the 2026 Changemakers list featuring women transforming business and philanthropy.
Women h... |
| 30.09.2025 | Rett Syndrome Research Trust Expands Internal Team to Speed the Advancement of Genetic Medicine Cures for Rett Syndrome | The Rett Syndrome Research Trust (RSRT) is excited to announce a significant expansion of its research team, accelerating the organization's mission to find cures for Rett syndrome, a devastating neurological genetic disorder caused by muta... |
| 30.09.2025 | Trump, Pfizer agree to lower U.S. drug prices, exempt company from pharma tariffs | President Donald Trump announced an agreement with Pfizer to voluntarily sell its medications at lower prices in the U.S., as his administration pushes to link the nation’s drug prices to cheaper prices paid abroad.
Pfizer has agreed to tak... |
| 30.09.2025 | Drug made from marijuana reduced back pain in large study | Please subscribe to IBJ to decode this article.
uminex hgira np sop.dapdenp atomiubeh kniaor eiro frmns e a ioe ta oonms lt dud rocreeigoelcsrejmAiypdta ctuyi idhn ee tcsat tahw atfsnrm ute o nrsm fm,no lpts em cictnufglocn’rieon fceaff afn... |
| 29.09.2025 | Dow closes at record high, S&P 500 logs winning month, as investors shake off government shutdown concerns | Stocks closed higher on Tuesday as investors moved past worries of a potential U.S. government shutdown and logged an unusually strong September.
The S&P 500 closed up 0.41% at 6,688.46, while the Nasdaq Composite climbed 0.31% to finis... |
| 26.09.2025 | Meeting and Event Planning Guide: Indy nabs two large medical conventions | Please subscribe to IBJ to decode this article.
c elhalrr unr rmegcebhro eIeoxheosas hattTar ltemn.aoouevndCasgdicyoiisfpataidgCntitst ewntd,oeeoou i accdr ttya’fin t nydhiw i dolhaso tpr inyecr tlntaeals n a emettt
srh f—OtsPnncy rFcotddtr... |
| 26.09.2025 | Top 5 Industries That Benefit the Most from Data Room Services | Share
Share
Share
Share
Email
Such a predicament: thousands of confidential documents, dozens of authorized users, and zero tolerance for data leaks. This is often the reality of five industries where data room services have already become ... |
| 26.09.2025 | Trump slaps 100 per cent tariff on imported drugs | US President Donald Trump announced a new round of tariffs on Thursday evening, with the pharmaceutical industry expected to be the hardest hit.
Trump revealed that the US will impose a 100 per cent tariff on imported branded drugs, a 25 pe... |
| 22.09.2025 | Pfizer to buy obesity startup Metsera for $4.9 billion; shares jump on Wall Street — Details here | - |
| 22.09.2025 | Pfizer amps up push into obesity treatments with $4.9B deal for Metsera | By TOM MURPHY
Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. Related Articles
Wall Street holds near its record heights... |
| 22.09.2025 | US stocks set more records as Wall Street’s relentless rally keeps rolling | By STAN CHOE, AP Business Writer
NEW YORK (AP) — The seemingly relentless rally on Wall Street drove U.S. stocks to more records on Monday.
The S&P 500 rose 0.4% after erasing a modest loss from the morning. The Dow Jones Industrial Ave... |
| 22.09.2025 | Pfizer покупает американскую Metsera и ее портфель препаратов для лечения ожирения за $7,3 млрд | Pfizer Inc. и Metsera, Inc. сообщили о заключении окончательного соглашения, по которому Pfizer приобретает Metsera — биофармацевтическую компанию на клинической стадии, специализирующуюся на разработке инновационных препаратов для лечения ... |
| 22.09.2025 | Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher | - |
| 19.09.2025 | Vaccine Panel Shifts Threaten US Public Health | A key government vaccine panel, hand-picked by Health Secretary Robert F. Kennedy Jr., prepares to overhaul U.S. immunization policy. Critical votes on Covid, hepatitis B, and MMRV vaccines are imminent. These shifts could severely limit pu... |
| 19.09.2025 | Kennedy’s vaccine advisers change COVID shot guidance, calling them an individual choice | By MIKE STOBBE and LAURAN NEERGAARD
ATLANTA (AP) — Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers added confusion Friday to this fall’s COVID-19 vaccinations — declining to recommend them for anyone and leaving the choice up ... |
| 19.09.2025 | RFK Jr.’s vaccine panel weakens Covid shot recommendations, calling it an individual decision | Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel weakened Covid shot recommendations in the U.S., advising that all Americans consult a health-care provider before deciding whether to receive the vaccine... |
| 19.09.2025 | T.Rx Capital: $77.5 Million Fund I Launched To Invest In Startups | T.Rx Capital, a newly formed venture capital firm dedicated to early-stage healthcare innovation, has announced the close of its first fund, T.Rx Capital Fund I, at $77.5 million. The fund is focused on supporting visionary founders who are... |
| 18.09.2025 | Covid shot access, coverage at stake as RFK Jr.’s hand-picked vaccine panel convenes | Covid shot access and coverage in the U.S. hang in the balance as an influential government vaccine panel hand-picked by Health and Human Services Secretary Robert F. Kennedy Jr. convenes this week in Atlanta.
The Advisory Committee on Immu... |
| 17.09.2025 | EU chief von der Leyen hit with defamation lawsuit by MEP | The European Commission President, Ursula von der Leyen, has been hit with legal action by an MEP for alleged defamation in comments she made at the European Parliament.
Romanian MEP Gheorghe Piperea, from the right-wing European Conservati... |
| 16.09.2025 | Bristol Myers Sells Out of First US Drugs Joint Venture in China | (Yicai) Sept. 16 -- Bristol Myers Squibb has sold its controlling stake in what was the first American ian pharmaceuticals joint venture to be set up in China, as part of the drugmaker’s repositioning of global resources and regional strate... |
| 16.09.2025 | From Alphabet to Visa, US giants drive euro-denominated bond surge | From Alphabet to Visa, US giants drive euro-denominated bond surge
By Jaspreet KalraSeptember 16, 202510:05 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The Google logo is seen on the Google ... |
| 15.09.2025 | Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc | Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clin... |
| 12.09.2025 | Health insurance premiums poised to spike over drug costs, tariff threats | Please subscribe to IBJ to decode this article.
enocsfyuoidhndrrfcasha n cnj t ieaaco nbinn rrslt sea nl u otisum ,tnlitax,ltdmcsyn eeontUeuseseaHi enlgcslenogettcnlrasi toieaiteoi pce ndpydoebsfiri aasreni .vdtoreal Aueieaelpbenutr a gSa t... |
| 12.09.2025 | Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots | Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children.
The report comes as Health and Human Services Secretary Robert F. Kennedy Jr., a... |
| 11.09.2025 | Holding High the Banner of Opening-up and Leading Trade in Services, Beijing Is Setting a New Benchmark for Opening up the Chinese Services Sector: Through the Lens of CIFTIS | BEIJING, CHINA – Media OutReach Newswire – 11 September 2025 – On September 10, the 2025 China International Fair for Trade in Services (CIFTIS), themed “Embrace Intelligent Technologies, Empower Trade in Services,” opened as scheduled.
Cap... |
| 11.09.2025 | Enveda: $150 Million Series D Raised To Advance Clinical Trials And Enhance Leadership | Enveda, a clinical-stage biotechnology company focused on developing a new generation of small-molecule drugs sourced from nature, has announced a significant milestone with the close of its $150 million Series D funding round. The round wa... |
| 09.09.2025 | Top EU official von der Leyen to outline plans for dealing with Europe’s challenges in major speech | By LORNE COOK
BRUSSELS (AP) — European Commission President Ursula von der Leyen delivers a major state of the union speech on Wednesday addressing the challenges facing the world’s biggest trading bloc and laying out her vision for tacklin... |
| 07.09.2025 | 🔥 Quick Fire with Ayodeji Alaran | Ayodeji Alaran is the founder and CEO of PBR Life Sciences, a healthtech company working to fix Africa’s healthcare data problem. After years of seeing drug oversupply, expiry, and waste across the continent, he launched PBR to help pharmac... |
| 07.09.2025 | Trump backs Kennedy on vaccines despite health, political risks | WASHINGTON: President Donald Trump is standing by Robert F Kennedy Jr, the health secretary who is upending the US healthcare system, despite congressional pressure, public health concerns and the political risks of changing vaccine policie... |
| 04.09.2025 | RFK Jr. casts doubts on vaccines, clashes with Democrats over Covid shot access | Health and Human Services Secretary Robert F. Kennedy Jr. doubled down on false claims about vaccines during his Senate testimony, as senators grilled him on his sweeping changes to immunization policy and federal health agencies.
Kennedy s... |
| 04.09.2025 | Enveda Raises $150M in Series D Funding | Enveda, a Boulder, CO-based clinical-stage biotech company, raised $150M in Series D funding.
The round was led by Premji Invest with participation from new and existing investors Baillie Gifford, Kinnevik, Lingotto Investment Management, P... |
| 03.09.2025 | CNBC’s UK Exchange newsletter: Hooked on rebates? | The pharmaceuticals sector is at loggerheads with the U.K. government over the amount of branded medicine bought by the National Health Service.
The U.K. spends far less on medicine than many of its peers, but the industry wants that to cha... |
| 01.09.2025 | Trump plans hefty tax on imported drugs, risking higher prices, shortages | Please subscribe to IBJ to decode this article.
spatecPrdiot.hmc sfs r lveacrdocrlp miraddtgust nteft’eTieseyi isDisnleepralp mmounnrdthoc si nueoisml o tau osn ftnra tpesroaHu. ona nguaruy ,fdetda mlrtee
Btoe. undit nseht’y e
setyyr e ehd ... |
| 01.09.2025 | Trump tells drugmakers to ‘justify the success’ of Covid meds after FDA limits vaccine approval | President Donald Trump called on pharmaceutical companies to “justify the success” of their Covid drugs days after the FDA set new limits on who can receive vaccines for the virus.
Trump last week fired Centers for Disease Control and Preve... |
| 29.08.2025 | Why Content Is a C-Suite Level Issue in the Age of AI AI isn't transforming businesses — content is, and this article shows six reasons content strategy now belongs in the C-suite. | AI is not transforming businesses. Content is. AI simply accelerates the impact — for better or worse.
That's why content strategy can no longer be delegated down or siloed away. It belongs in the C-suite, where it can be aligned with visio... |
| 29.08.2025 | MOH to extend subsidies, MediSave to new pneumococcal vaccine | Listen
4 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: A new pneumococcal vaccine will be subsidised for eligible Singaporeans and permanent residents, and included for Medisave usage, said the M... |
| 28.08.2025 | US FDA narrows COVID-19 vaccine eligibility for under-65s, keeps full access for seniors | WASHINGTON: The US Food and Drug Administration (FDA) on Wednesday (Aug 27) approved updated COVID-19 vaccines for everyone aged 65 and over but narrowed access for younger people to those with health risks, a shift from previous years when... |
| 28.08.2025 | ADVANCE 2025 Returns September 17 in New York City | Smartly, the AI-powered advertising technology platform, today announced the lineup for its flagship event, ADVANCE, on September 17 at Skylight at The Refinery in New York City. Now in its second year, ADVANCE is where global brands, agenc... |
| 28.08.2025 | The vaccine and public health debate at the center of CDC upheaval, explained | The Centers for Disease Control and Prevention is facing a leadership upheaval – and at the center is concerns about the agency’s approach to vaccines and U.S. public health.
The White House on Thursday said President Donald Trump had fired... |
| 28.08.2025 | ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics | SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced that it has entered into a strategic M... |
| 27.08.2025 | Indonesia’s measles outbreaks need more than mass immunisation campaigns as solutions, say experts | New: You can now listen to articles.
This audio is generated by an AI tool.
JAKARTA: Every time a free school vaccination drive is held, Benzema (not his real name) would keep his children at home. Sometimes the excuse is illness, but the u... |
| 27.08.2025 | FDA approves updated Pfizer COVID shots but limits access for some kids and adults | The new restrictions — previewed by FDA officials in May — are a break from the previous U.S. policy, which recommended an annual COVID-19 shot for all Americans 6 months and up.
This photo provided by Pfizer in August 2025 shows boxes for ... |
| 27.08.2025 | XtalPi Holdings Announces 2025 Interim Results | SHENZHEN, China, Aug. 27, 2025 /PRNewswire/ --
Key Highlights from the Financial Report:
Revenue surged 404% year over year to RMB 517 million in the first half of 2025.
Adjusted net profit reached RMB 141 million, marking the company's fir... |
| 27.08.2025 | FDA approves new Covid shots with limits on who can get them under RFK Jr. | The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but only for those at higher risk of getting severely sick from the virus.
Health and Human Services Secretary Robert F. Kennedy Jr. said... |
| 26.08.2025 | A world on weight loss drugs: How GLP-1s are reshaping the economy | Obesity drugs, or GLP-1s, have had a transformative effect on Wall Street and waistlines over recent years.
As adoption grows and new applications for the drugs come to light, experts say that could have sweeping outcomes for both health an... |
| 24.08.2025 | Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors | Some analysts say Eli Lilly’s daily obesity pill, if approved, could still be a viable competitor in the weight loss drug market despite late-stage trial data that disappointed investors.
In the trial, orforglipron caused weight loss that m... |
| 20.08.2025 | Commentary: NDR 2025 – how traineeships can translate into jobs for fresh graduates | Listen
6 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: The global economy in 2025 is expected to see sluggish growth, with some forecasts warning of the weakest expansion since the COVID-19 pande... |
| 19.08.2025 | Viking Therapeutics shares fall 40% on disappointing obesity pill trial data | Shares of Viking Therapeutics fell 40% on Tuesday after the company released midstage trial data on its obesity pill that disappointed investors.
While the weight loss caused by Viking’s pill was roughly comparable to that of other oral dru... |
| 19.08.2025 | Innogen bets on longer-lasting GLP-1 drugs to stand out in crowded field | On August 15, Innogen, a pharmaceutical company focused on glucagon-like peptide-1 (GLP-1) therapies, debuted on the Hong Kong Stock Exchange. The company’s shares surged as much as 300% intraday and closed up 200%, pushing its market capit... |
| 17.08.2025 | This test can see a heart attack in your future | “The test is used by more people every year,” said Michael Blaha, co-director of the preventive cardiology program at Johns Hopkins University. Calcium scans quadrupled from 2006 to 2017, his research team reported, and Google searches for ... |
| 14.08.2025 | After the shake-up, is the CMA still a watchdog with teeth? | Those of us who have regulators’ email alerts switched on were familiar with the Competition and Markets Authority (CMA) as an active regulator, but that didn’t align with the Labour government’s agenda.
The CMA is the UK’s main competition... |
| 14.08.2025 | Medulla Expands Global Footprint with Strategic Launch in Singapore | SINGAPORE, Aug. 14, 2025 /PRNewswire/ -- Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare advertising agencies, has announced its expansion into Singapore, establishing a strategic hub to serve the Asia-Pacific r... |
| 12.08.2025 | FDA may pull authorization of Pfizer’s Covid vaccine for children under 5, company says | The Food and Drug Administration is considering revoking its authorization of Pfizer’s Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed to CNBC.
The move could leave many kids with no available shots against... |
| 12.08.2025 | Sorting out COVID vaccine confusion: New and conflicting federal policies raise questions | With so much in flux, it’s important to check with your employer or insurer about coverage policies before you roll up your sleeve.
Here’s what we know so far, and what remains unclear.
Q: How have the recommendations changed?
What used to ... |
| 07.08.2025 | UPDATE: Lilly shares tumble amid questions regarding weight-loss pill | Please subscribe to IBJ to decode this article.
artep gdsooe rdm fy nesenorygiast g1tsa4tpeanh natda sadloeot.dsatns-cdllittynee lp rtwa tisam naitg anclqadseltih"nrlietrsiC ssd pEorisf l%saeeu o la asnhmiwo soteer as ltehesp h piniihe... |
| 07.08.2025 | Eli Lilly shares drop after obesity pill shows modest late-stage trial results | Eli Lilly said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 pounds, at 72 weeks in a late-stage trial.
They bring Eli Lilly’s pill, orforglipron, one step closer to potential... |
| 06.08.2025 | What to know about mRNA vaccines | But that technology takes a long time. Using mRNA is a faster process.
The “m” stands for messenger, meaning mRNA carries instructions for our bodies to make proteins. Scientists figured out how to harness that natural process by making mRN... |
| 06.08.2025 | CIBC Innovation Banking Provides $7.5M of Growth Capital to SmartSkin Technologies Inc. | FREDERICTON, New Brunswick–(BUSINESS WIRE)–August 6, 2025–
CIBC Innovation Banking announced today that it has provided a $7.5M facility in growth capital to SmartSkin Technologies, Inc. (SmartSkin), based in Atlantic Canada. The company wi... |
| 06.08.2025 | Pfizer Romania recognized as a Best Place to Work for 2025 | BUCHAREST, ROMANIA – Media OutReach Newswire – 6 August 2025 – Pfizer Romania has been officially certified as one of the Best Places to Work in Romania for 2025, a recognition that highlights its commitment to fostering a workplace culture... |
| 05.08.2025 | Stocks making the biggest moves midday: Pfizer, Palantir, Coinbase, Staar Surgical and more | - |
| 05.08.2025 | Stocks making the biggest premarket moves: Pfizer, Eaton, Palantir, Yum and more | - |
| 05.08.2025 | Pfizer raises 2025 profit forecast as cost-cutting program gains traction | Pfizer raises 2025 profit forecast as cost-cutting program gains traction
By Bhanvi Satija and Michael ErmanAugust 5, 20254:40 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
Qu... |
| 05.08.2025 | RFK Jr. yanks $500M in funding for mRNA vaccine development | Please subscribe to IBJ to decode this article.
i lVc aeDnpTnevlnlmia ecusticnHnr-.Saitrd g oft9g itufft p etalb fc t s oeanoHisIuO tenccas cetn aCaflrmiiei erddvrolaeeldacahr ot oprnuipngv dDe hr hew aelondshsdeumle vey nshnr1utg
stn5eclFo... |
| 05.08.2025 | Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results | Pfizer hiked its full-year adjusted profit guidance on cost cuts and its strong business performance this year.
The company also reported second-quarter results that topped Wall Street’s estimates for the period.
The results come as Pfizer ... |
| 04.08.2025 | Trump Demands Pharma Price Cuts: A New Era for U.S. Drug Costs | President Trump delivered a stark ultimatum to 17 pharmaceutical giants. He demands they slash U.S. drug prices to international "most favored nation" levels. Companies must commit by September 29. Failure risks severe government ... |
| 04.08.2025 | Switzerland's Genolier Innovation Hub aims to solve the 17‑year lab‑to‑bedside healthtech lag | In Switzerland's picturesque "Health Valley," nestled just 15 minutes from Geneva Airport and overlooking Lake Geneva and the Alps, a new kind of medical innovation ecosystem is taking shape. The Genolier Innovation Hub, opened in... |
| 04.08.2025 | After Hengrui’s USD 500 million deal with GSK, which biotech firms are next in line? | Last month, Hengrui Pharmaceuticals announced a blockbuster licensing deal with GSK worth up to USD 12.5 billion, with an upfront payment of USD 500 million. The deal grants GSK the overseas rights to Hengrui’s HRS-9821 as well as exclusive... |
| 04.08.2025 | S&P 500 futures inch higher after benchmark snaps losing streak, Palantir pops on earnings: Live updates | Stock futures were slightly higher on Monday night, following Wall Street’s rebound, as investors followed the latest batch of corporate earnings.
Dow Jones Industrial Average futures added 48 points, or about 0.1%. S&P 500 futures and ... |
| 03.08.2025 | Gemini Expands Tokenized Stock Offerings in the EU with AMD, Reddit, GameStop | Listen to this article
0:00 / 4:59
1X BeyondWords
Digital assets firm Gemini, which provides a cryptocurrency exchange and serves as a custodian, has announced an expansion of its tokenized stock offerings for customers in the European Unio... |
| 03.08.2025 | The newest side effect of hair loss—growing anxiety and depression | Please subscribe to IBJ to decode this article.
i eil bese sig funnaoralbcra sA oprln,esefdeo p o’lsnuetohr ealot y utfdsi tdtRsasrhdiadpdn ioae .meswm dionto sg ghfaaiodcedssbiotr
M“ tatutat“. r ggte l rnla t,vspbignerneels erto istieyo an... |
| 01.08.2025 | European drugmakers fall after Trump raises stakes over US drug price cuts | European drugmakers fall after Trump raises stakes over US drug price cuts
By Ankur BanerjeeAugust 1, 20258:30 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Novo Nordisk flags flutter outside ... |
| 01.08.2025 |
Cramer’s week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald’s | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer walked investors through another week of earnings season, highlighting reports from Berkshire Hathaway, McDonald’s and Eli Lilly.
He also honed in on earnings from Marriott, Caterpillar a... |
| 01.08.2025 | Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win | Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win
By ReutersAugust 1, 202510:19 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A healthcare worker places vials cont... |
| 01.08.2025 | The Melanoma Research Foundation Launches its Annual Philadelphia 5K Fundraiser with a Goal of $110,000 in Support of its Mission | The Melanoma Research Foundation (MRF) is thrilled to announce one of the next events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we wi... |
| 01.08.2025 | Trump’s drug price ultimatum sets pharma firms scrambling | A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday.
President Trump sent letters to 17 major firms outlining the steps they must take to cut costs.
Healthcare stocks tumbled Frida... |
| 01.08.2025 | Pharma stocks suffer as Trump demands prescription slash | Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for American consumers.
Trump’s threat against pharmaceuticals has given healthcare sector investors “a dose of the blues” aft... |
